ERIS Lifescience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406M01024
  • NSEID: ERIS
  • BSEID: 540596
INR
1,552.40
-6 (-0.39%)
BSENSE

Dec 05

BSE+NSE Vol: 35.59 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
792.41
773.00
705.30
727.45
741.17
719.72
550.93
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
792.41
773.00
705.30
727.45
741.17
719.72
550.93
Raw Material Cost
82.58
70.10
68.28
69.43
72.16
66.47
51.17
Purchase of Finished goods
146.09
104.26
95.98
133.22
118.35
125.57
58.51
(Increase) / Decrease In Stocks
-26.26
10.28
5.99
-25.77
-4.24
-11.45
8.50
Employee Cost
137.45
144.43
121.45
125.39
125.63
132.62
102.48
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
164.34
167.22
161.21
174.87
164.76
156.52
181.84
Total Expenditure (Excl Depreciation)
504.20
496.29
452.91
477.14
476.66
469.73
402.50
Operating Profit (PBDIT) excl Other Income
288.21
276.71
252.39
250.31
264.51
249.99
148.43
Other Income
2.81
2.69
7.95
4.22
4.55
1.64
15.15
Operating Profit (PBDIT)
291.02
279.40
260.34
254.53
269.06
251.63
163.58
Interest
49.55
48.68
54.28
57.17
59.47
60.37
33.03
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
241.47
230.72
206.06
197.36
209.59
191.26
130.55
Depreciation
69.08
70.51
77.25
81.00
80.48
75.74
53.80
Profit Before Tax
172.67
161.10
128.87
116.36
129.11
115.52
76.75
Tax
38.20
36.00
26.52
29.30
32.76
25.97
-2.95
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
134.19
124.21
102.29
87.06
96.35
89.55
79.70
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
134.19
124.21
102.29
87.06
96.35
89.55
79.70
Share in Profit of Associates
0.28
0.89
0.06
0.00
0.00
0.00
0.00
Minority Interest
14.28
7.11
8.51
3.30
4.76
6.24
8.67
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
120.19
117.99
93.84
83.76
91.59
83.31
71.03
Equity Capital
13.62
13.62
13.62
13.61
13.61
13.61
13.60
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,077.54
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
8.82
8.66
6.89
6.15
6.73
6.12
5.22
Diluted Earnings per share
8.81
8.64
6.89
6.15
6.72
6.1
5.21
Operating Profit Margin (Excl OI)
36.48%
35.86%
35.92%
34.66%
35.8%
34.93%
27.12%
Gross Profit Margin
30.56%
29.9%
29.33%
27.33%
28.36%
26.73%
23.85%
PAT Margin
17.02%
16.21%
14.57%
12.06%
13.04%
12.51%
14.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 6.91% vs 46.68% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 31.23% vs -25.80% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 8.96% vs 46.03% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is -16.68% vs 264.85% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of ERIS Lifescience With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
792.41
514.27
278.14
54.08%
Other Operating Income
0.00
0.00
0.00
Total Operating income
792.41
514.27
278.14
54.08%
Raw Material Cost
82.58
227.64
-145.06
-63.72%
Purchase of Finished goods
146.09
0.00
146.09
(Increase) / Decrease In Stocks
-26.26
-44.03
17.77
40.36%
Employee Cost
137.45
80.37
57.08
71.02%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
45.96
-45.96
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
164.34
48.79
115.55
236.83%
Total Expenditure (Excl Depreciation)
504.20
358.73
145.47
40.55%
Operating Profit (PBDIT) excl Other Income
288.21
155.54
132.67
85.30%
Other Income
2.81
1.80
1.01
56.11%
Operating Profit (PBDIT)
291.02
157.34
133.68
84.96%
Interest
49.55
5.37
44.18
822.72%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
241.47
151.97
89.50
58.89%
Depreciation
69.08
22.54
46.54
206.48%
Profit Before Tax
172.67
129.44
43.23
33.40%
Tax
38.20
32.58
5.62
17.25%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
134.19
96.85
37.34
38.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
134.19
96.85
37.34
38.55%
Share in Profit of Associates
0.28
0.00
0.28
Minority Interest
14.28
0.00
14.28
Other related items
0.00
0.00
0.00
Consolidated Net Profit
120.19
96.85
23.34
24.10%
Equity Capital
13.62
12.90
0.72
5.58%
Face Value
1.00
10.00
0.00
Reserves
3,077.54
0.00
3,077.54
Earnings per share (EPS)
8.82
75.08
-66.26
-88.25%
Diluted Earnings per share
8.81
75.49
-66.68
-88.33%
Operating Profit Margin (Excl OI)
36.48%
30.24%
0.00
6.24%
Gross Profit Margin
30.56%
29.55%
0.00
1.01%
PAT Margin
17.02%
18.83%
0.00
-1.81%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 792.41 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 2.51% vs 9.60% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 6.91% vs 46.68% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 120.19 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 1.86% vs 25.74% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 31.23% vs -25.80% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 288.21 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 4.16% vs 9.64% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 8.96% vs 46.03% in Sep 2024

Quarterly - Interest
Interest 49.55 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 1.79% vs -10.32% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -16.68% vs 264.85% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 36.48%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024